Can yeast and bacterial dysbiosis reinforce each other in the gut?

The gut mucosal ecosystem relies on a delicate equilibrium between fungal and bacterial communities. When this balance is disrupted, yeast and bacterial dysbiosis engage in a bidirectional feed-forward loop that mutually reinforces mucosal barrier dysfunction and immune activation.

Disruption of colonization resistance

• Reciprocal Overgrowth: A healthy bacterial microbiota exerts colonization resistance against opportunistic fungi like Candida albicans. When bacterial communities are depleted, this resistance collapses, permitting fungal proliferation and hyphal transition.
• Microbiome Reshaping: Conversely, C. albicans overgrowth actively drives bacterial dysbiosis, reducing overall bacterial diversity and shifting the niche to favor the expansion of opportunistic bacterial taxa, such as Enterococcus.

Mucosal barrier and immunological decay

• Junctional Degradation: C. albicans secretes Kex2-processed peptides and hypha-associated enzymes that directly degrade crucial tight and adherens junction proteins, including E-cadherin, occludin, JAM-A, and claudins. Concurrently, bacterial dysbiosis—marked by the loss of short-chain fatty acid (SCFA)-producing taxa—deprives the epithelium of barrier-supportive signaling, permitting bacterial proteases to further cleave E-cadherin.
• Immune Dysregulation: Epithelial leakiness facilitates the translocation of fungal and bacterial pathogen-associated molecular patterns (PAMPs), amplifying inflammatory mucosal signaling. Fungi engage the Dectin-1-CARD9 pathway to drive Th17-mediated inflammatory cascades, elevating levels of IL-23, IL-1beta, and IL-17/IL-22. This is exacerbated by bacterial dysbiosis, which impairs regulatory SCFA-Treg and tryptophan-indole-AHR axes while suppressing protective antimicrobial peptides like LL-37/CRAMP.

Bottom line

• Yeast and bacterial dysbiosis cooperatively drive a pathogenic loop: a breakdown in colonization resistance permits cross-kingdom overgrowth, which dismantles epithelial tight junctions and fuels persistent, Th17-mediated mucosal inflammation.